drugset / Trial / NCT00010036
Carboplatin Plus Irinotecan in Treating Patients With Glioblastoma Multiforme
Treatment
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of combining carboplatin with irinotecan in treating patients who have glioblastoma multiforme.
Timeline
- Start
- 1999-05
- Primary completion
- 2001-10
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Carboplatin | Small molecule | — | Intravenous |
| Subject | Irinotecan | Small molecule | — | Intravenous |